HK1179823A1 - Methods for treating methotrexate-resistant disorders with 10-propargyl-10- deazaaminopterin 10--10- - Google Patents

Methods for treating methotrexate-resistant disorders with 10-propargyl-10- deazaaminopterin 10--10-

Info

Publication number
HK1179823A1
HK1179823A1 HK13107058.9A HK13107058A HK1179823A1 HK 1179823 A1 HK1179823 A1 HK 1179823A1 HK 13107058 A HK13107058 A HK 13107058A HK 1179823 A1 HK1179823 A1 HK 1179823A1
Authority
HK
Hong Kong
Prior art keywords
deazaaminopterin
propargyl
methods
resistant disorders
methotrexate
Prior art date
Application number
HK13107058.9A
Other languages
English (en)
Chinese (zh)
Inventor
Gijsbertus J Pronk
Original Assignee
Allos Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allos Therapeutics Inc filed Critical Allos Therapeutics Inc
Publication of HK1179823A1 publication Critical patent/HK1179823A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK13107058.9A 2010-06-02 2013-06-17 Methods for treating methotrexate-resistant disorders with 10-propargyl-10- deazaaminopterin 10--10- HK1179823A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35087110P 2010-06-02 2010-06-02
PCT/US2011/038953 WO2011153368A1 (en) 2010-06-02 2011-06-02 Methods for treating methotrexate-resistant disorders with 10-propargyl-10-deazaaminopterin

Publications (1)

Publication Number Publication Date
HK1179823A1 true HK1179823A1 (en) 2013-10-11

Family

ID=45067077

Family Applications (1)

Application Number Title Priority Date Filing Date
HK13107058.9A HK1179823A1 (en) 2010-06-02 2013-06-17 Methods for treating methotrexate-resistant disorders with 10-propargyl-10- deazaaminopterin 10--10-

Country Status (16)

Country Link
US (1) US20130143891A1 (ko)
EP (1) EP2575466B1 (ko)
JP (1) JP5897558B2 (ko)
KR (1) KR20130115993A (ko)
CN (1) CN102984940B (ko)
AU (1) AU2011261384B2 (ko)
BR (1) BR112012030764A2 (ko)
CA (1) CA2800900A1 (ko)
DK (1) DK2575466T3 (ko)
ES (1) ES2541689T3 (ko)
HK (1) HK1179823A1 (ko)
IL (1) IL223078A (ko)
MX (1) MX339793B (ko)
RU (1) RU2586299C2 (ko)
WO (1) WO2011153368A1 (ko)
ZA (1) ZA201209673B (ko)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9901578B2 (en) 2007-08-17 2018-02-27 Allos Therapeutics, Inc. Combination of 10-propargyl-10-deazaaminopterin and erlotinib for the treatment of non-small cell lung cancer
ES2596953T3 (es) 2010-02-02 2017-01-13 Allos Therapeutics, Inc. Diastereómeros de 10-propargil-10-desazaaminopterina para uso en el tratamiento del cáncer de pulmón
RU2013102373A (ru) * 2010-08-10 2014-09-20 Аллос Терапьютикс, Инк. Продления выживаемости без прогрессирования заболевания с применением 10-пропаргил-10-деазааминоптерина
WO2013177713A1 (en) * 2012-05-31 2013-12-05 Alphora Research Inc. Process for preparation of an antifolate agent
WO2014020553A1 (en) * 2012-08-03 2014-02-06 Fresenius Kabi Oncology Ltd. Salts of pralatrexate
CN104628727B (zh) * 2013-11-07 2018-08-21 正大天晴药业集团股份有限公司 一种普拉曲沙的晶型及其制备方法
CN104628728A (zh) * 2013-11-08 2015-05-20 深圳海王药业有限公司 一种普拉曲沙的制备方法
CN103588775B (zh) * 2013-11-12 2016-08-17 连云港恒运医药科技有限公司 普拉曲沙降解杂质及其制备方法
CN105272983B (zh) * 2014-06-12 2021-01-15 连云港润众制药有限公司 一种高纯度普拉曲沙固体及其制备方法
CN107488178B (zh) * 2016-06-10 2020-05-12 山东新时代药业有限公司 一种高纯度普拉曲沙中间体的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5354751A (en) * 1992-03-03 1994-10-11 Sri International Heteroaroyl 10-deazaamino-pterine compounds and use for rheumatoid arthritis
EP0638079B1 (en) * 1992-04-29 1999-12-15 Sri International Deazaaminopterins for treatment of inflammation
EP2258702A3 (en) * 1996-07-17 2011-11-30 Sloan-Kettering Institute For Cancer Research Purified compositions of 10-Propargyl-10-Deazaaminopterin and method of using same in the treatment of tumors
US6323205B1 (en) * 1996-07-17 2001-11-27 Sloan-Kettering Institute For Cancer Research Combinations of 10-propargyl-10-deazaaminopterin and taxols and methods of using same in the treatment of tumors
BRPI0510895A (pt) * 2004-05-30 2007-11-27 Sloan Kettering Inst Cancer formulação farmacêutica de 10-propargila-10-deazaaminopterina para tratamento de linfoma de célula t

Also Published As

Publication number Publication date
KR20130115993A (ko) 2013-10-22
DK2575466T3 (en) 2015-07-20
MX339793B (es) 2016-06-10
EP2575466A4 (en) 2013-07-17
ES2541689T3 (es) 2015-07-23
EP2575466B1 (en) 2015-04-08
AU2011261384B2 (en) 2015-01-22
IL223078A (en) 2016-07-31
AU2011261384A1 (en) 2012-12-06
RU2012148767A (ru) 2014-07-20
ZA201209673B (en) 2014-03-26
US20130143891A1 (en) 2013-06-06
BR112012030764A2 (pt) 2015-09-29
MX2012013740A (es) 2013-07-29
WO2011153368A1 (en) 2011-12-08
CN102984940A (zh) 2013-03-20
EP2575466A1 (en) 2013-04-10
IL223078A0 (en) 2013-02-03
JP5897558B2 (ja) 2016-03-30
CA2800900A1 (en) 2011-12-08
CN102984940B (zh) 2016-01-13
RU2586299C2 (ru) 2016-06-10
JP2013527245A (ja) 2013-06-27

Similar Documents

Publication Publication Date Title
IL226401A0 (en) Methods for treating disorders related to @fgfBA
ZA201401438B (en) Methods for treating cardiovascular disorders
EP2611496A4 (en) Methods of Treatment
ZA201307225B (en) Methods for genomic modification
HUE040276T2 (hu) Eljárás metabolikus rendellenességek kezelésére
ZA201304334B (en) Methods for diagnosing and treating eye-length related disorders
HK1179823A1 (en) Methods for treating methotrexate-resistant disorders with 10-propargyl-10- deazaaminopterin 10--10-
SI2635299T1 (sl) Postopki za zdravljenje motenj izgube las
EP2582374A4 (en) METHOD FOR TREATING NERVOUS ELEMENTS
IL225623A0 (en) Psoriasis treatment methods
IL260077A (en) Methods of treating excess bilirubin in the blood with stanoporfin
EP2590645A4 (en) METHOD FOR TREATING BIPOLAR DISORDER
ZA201404422B (en) Methods for treating cardiovascular disorder
IL218633A0 (en) Methods for treating psoriasis
IL220594A0 (en) Treatment method
EP2654749A4 (en) PROCESS FOR TREATING COPD
HK1216848A1 (zh) 用於治療胃腸道病症的方法
GB201010359D0 (en) Compounds for treating proliferative disorders
EP2773774A4 (en) BIOMARKERS FOR THE TREATMENT OF TSLP
EP2575799A4 (en) METHOD FOR THE TREATMENT OF INFLAMMABLE AUTOIMMUNE DISEASES
EP2704710A4 (en) COMPOSITION FOR TREATING AUTOIMMUNE DISORDERS AND RELATED METHODS
ZA201209757B (en) Methods of treating conditions associated with overactive bladder
HK1209040A1 (en) Methods for treating vestibulotoxicity
GB201105523D0 (en) Treatment method
AU2012901917A0 (en) Methods for treating cachexia

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20190606